Glycocalyx scaffolding with synthetic nanoscale glycomaterials
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Materials.
6'-sialyllactose and 3'sialyllactose glycan were obtained from Carbosynth (San Diego, CA). Unless otherwise stated, all other chemicals were purchased from Sigma Aldrich. Purchased starting materials were used as received unless otherwise indicated. Size exclusion chromatography was performed on a Hitachi Chromaster system equipped with an RI detector and a 5 µm, mixed bed, 7.8 mm I.D. x 30 cm TSKgel column (Tosoh Bioscience). Polymers were analyzed using an isocratic method: 0.7 mL/min in DMF (0.2% w/v LiBr, 70 o C). AlexaFluor 488-C 5 -malelimide was purchased from Molecular Probes (Cat # A10254). DSPE-PEG(2000)-DBCO was purchased from Avanti Lipids (Cat # 880229). PD-10 columns were purchased from GE Healthcare Life Sciences (Cat. # 17085101). Quick Spin Columns for radiolabeled DNA purification were purchased from Roche Diagnostics (Cat. # 11273913001).
Synthesis of 6'-sialyllactose-azide triethylammonium salt (1).
Installation of the reducing-end azide was achieved by using similar methods previously reported.
1 , 2 In 1 mL of 4:1 D 2 O:CH 3 CN, 6'-sialyllactose (28.4 mg, 0.0433 mmol) and triethylamine (30 µL, 0.2116 mmol) were mixed and stirred at 0 o C for 5 minutes. Freshly recrystallized ADMP (2-azido-1,3-dimethylimidazolinium hexafluorophosphate; 37 mg, 0.1300 mmol; previously synthesized as previously described 3 ) was added to the stirred solution at 0 o C and allowed to react for 3h. NMR of the crude mixture after 3h showed loss of anomeric peaks from 6'-sialyllactose (65% conversion). The reaction mixture was then diluted with 4 mL of water containing 0.1% trifluoroacetic acid (TFA) and a 1. 
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Synthesis of 3'-sialyllactose glycopolymer (2) from monomer (2a).
RAFT polymerization. The RAFT polymerization of this Boc-protected Nmethylaminooxypropylacrylamide (2a) monomer has previously been described. 4 A Schlenk flask equipped with a magnetic stir bar was charged with an azide-terminated chain transfer agent (2a, 38.58 mg, 80.9 µmol, 0.07 mol% with respect to 2a), followed by the radical initiator AIBN (11.25 mg. 68.5 µmol, 0.06 mol% with respect to 2a), and the tert-butyl (3-acrylamidopropoxy)methyl carbamate monomer (2a; 296 mg, 1.15 mmol, delivered as 420 µL of a 360 mM solution in anhydrous dioxane), and anhydrous dioxane (172 mg). After degassing with six free-pump-thaw cycles, the reaction was allowed to proceed at 65 °C for seven hours. The reaction was quenched by submerging the flask in a dry ice-acetone bath. The mixture was then diluted in ether, and precipitated three times in hexanes. The resulting residue was concentrated in CHCl 3 and dried under high-vacuum to yield polymer (2c; 184 mg, 62.2%). 1 H NMR analysis of polymer backbone 2c.
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End-deprotection and fluorophore labeling. Polymer 2c (9.38 mg) end-deprotection was achieved by reaction with n-butylamine in THF (20 mM, 0.5 mL) for 2 hours at 0 °C. Following dilution in ether and precipitation with excess hexanes (3x), the end-deprotected polymer (2d) was isolated as a white solid (7.99 mg, 81.3%). 1 H NMR (CDCl 3 , 300mHz) δ (ppm): 3.90-3.65 (bs, 2H), 3.35-2.80 (bm, 5H), 1.80-1.05 (bm, 16H). GPC (DMF, 0.2% LiBr): Mw = 6826, Mn = 6030, Đ = 1.132, DP ≈ 22. UV-Vis 310 nm (CH 2 Cl 2 , 100 µM) = 0.075. The isolated material (7.99 mg) was then reacted with an AlexaFluor 488 C 5 -maleimide/DMF solution (1.1 eq; 2 mM, 694 µL) overnight at room temperature. The resulting material was diluted in ether, precipitated in excess hexanes (3x), dand ried under high-vacuum to yield the AlexaFluor488-labeled polymer (2e; 6.63 mg, 82.9%). Fig. S5 . GPC analysis of polymer backbone (2c; solid) and end-deprotected polymer (2d; dotted). A higher molecular weight species is observed in 2d (dotted) due to spontaneous oxidation of the free thiols of the polymer to form disulfide bridges. Boc deprotection and glycan ligation. The AlexaFluor488-labeled polymer backbone 2e (6.63 mg) was reacted with a freshly prepared mixture of chlorotrimethylsilane (3 M) and phenol (1 M) in DCM (0.5 mL) for 2 hours, dark, at RT. The mixture was then precipitated in ether following dilution in methanol. After drying the precipitate under a nitrogen stream, the product was dissolved in water, isolated by a PD-10 column, frozen, and lyophilized to yield the Bocdeprotected polymer 2f (2.69 mg, 61%). 1 H NMR (D 2 O, 300 MHz) δ (ppm): 3.90-3.65 (bs, 2H), 3.35-2.80 (bm, 5H), 1.80-1.05 (bm, 16H). UV-Vis spectrophotometry was used to determine AlexaFluor488 labeling efficiency of this water-soluble polymer: 2f, (AlexaFluor488, λ max : 495 nm in H 2 O) = 58%. The resulting polymer 2f (2.69 mg) was then dissolved in a sodium acetate buffer (1 M NaOAc, 1 M urea, pH 4.5) such that the solution contains 200 mM of the polymer side chains. Then, a PCR tube (0.5 mL) containing 3'-sialyllactose (9.12 mg, 1.1 eq.) was charged with the solution of 2f (63.3 µL), and the viscous solution was heated to 50 °C in a thermocycler for 72 hours. The resulting glycopolymer was purified via QuickSpin DNA columns using deuterated phosphate buffer (150 mM NaCl, 100 mM phosphate, pD 7.4), to yield 2 (0.5 mL). The final concentration was determined by UV-Vis analysis and the AlexaFluor488 labeling efficiency ([pol] = 908 µM).
1 H NMR analysis was used to determine glycan ligation efficiencies (45%). Cellular remodeling with 6'-SL glycolipid or 3'-SL glycopolymer. CHO-Lec2 cells were seeded to confluency 24 hours prior to incubation on tissue-culture treated 24-well plates. Next day, cells were washed once with DPBS (-Ca, -Mg), and incubated with desired concentrations of the material in MEMα for 1 hour at 37 °C, 5% CO 2 . Cells were visually checked for general health after incubation with the polymers by microscopy. No significant effects on cellular morphology were observed up to 1 mM final concentrations of either material. The cells were then washed twice with DPBS, trypsinized for 3-5 minutes to detach adherent cells, neutralized with an equal volume of MEMα + 10%FBS, and harvested into 1.5 mL eppendorf tubes. Cell suspensions were then pelleted (300 xg, 4 min, RT), washed once with DPBS, and fixed (1% PFAPBS) for 30-60 minutes at 4°C. After two sequential pelleting and washing steps, the cell suspensions were then stained for sialic acids with bMALII (1:100; 10 µg/mL) or Dy649 (1:100; 5 µg/mL) in 1% BSA/DPBS (+Ca, + Mg) overnight at 4°C, with gentle agitation. bMAL samples were washed and pelleted twice prior to labeling with Cy5-Streptavidin (1:500) in 1% BSA/DPBS (+Ca, + Mg) for an additional hour at 4 °C. Samples were further washed and pelleted twice prior to flow cytometry analysis. Graphs were generated using GraphPad Prism (v 6.0). Bar graphs and XY-graphs are depicted as means + SD of duplicate wells.
Flow cytometry. CHO-Lec2 or CHO-K1 (WT) cells were dissociated as before, and analyzed on a BD Accuri C6 flow cytometer. During collection, cells were gated using a FSC-H vs. SSC-H scatter plot, and 10, 000 cells in the relevant gate were collected per sample. FlowJo (v. 10) was then used to analyze the results.
Fluorescence microscopy. All imaging and processing was performed with a Zeiss AxioVert.A1 epifluorescence microscope and ZEN software, respectively. For visualizing polymer incorporation via the AlexaFluor488 fluorophore, cells in 24-well plates were fixed in 4% PFA/PBS for 10 mins at RT, washed twice with DPBS, and imaged directly in DPBS. To visualize SNA staining, cells were similarly fixed, and were then incubated with bSNA (1:25; 40 µg/mL) in 1% BSA/DPBS (+Ca, +Mg) overnight at 4°C, with gentle agitation. After washing twice, cells were further incubated in Cy5-Streptavidin (1:400) in 1% BSA/DPBS (+Ca, + Mg) for an additional hour at RT. Cells were imaged directly in DPBS after two additional washes. 
